文献速递乳腺癌放疗放疗物理与技术

基于拓扑学方法减轻保乳放疗中瘤床位置变化所致剂量学不确定性

A topology-based method to mitigate the dosimetric uncertainty caused by the positional variation of the boost volume in breast conservative radiotherapy.
PubMed 文献 · Radiat Oncol · 2017-03-20

多因素分析显示BMI是手术夹位移的唯一相关因素,高BMI患者被分层为高变异组,其系统误差和随机误差更大,所需PTV-H外扩边界在前后、头脚、左右方向分别为7、10、10 mm(高变异组)和4、9、6 mm(低变异组)。新计划中心脏剂量无显著差异,但同侧肺剂量参数普遍更高。

要点

  • 高BMI与瘤床位置不确定性增大相关,可据此分层患者。
  • 高变异组所需PTV-H外扩边界大于低变异组。
  • 增大边界后心脏剂量无显著差异,但同侧肺剂量参数更高。

核心结论

  • 接受辅助放疗的乳腺癌患者中,较高BMI与瘤床位置不确定性增大相关,应考虑更宽的外扩边界。

主要发现

  • 单因素分析中,较大乳房厚度、较大乳房体积、较高BMI及不同肿瘤位置与瘤床位置不确定性增大相关。
  • 多因素分析中BMI是手术夹位移的唯一相关因素,高BMI患者被分层为高变异组。
  • 以骨性结构配准时,高变异组手术夹位移的系统误差和随机误差均更大。

关键数值与推荐

  • 高变异组和低变异组在前后、头脚、左右方向的PTV-H外扩边界分别为7、10、10 mm和4、9、6 mm。

临床怎么用

  • 对高BMI患者应考虑更宽的外扩边界,并通过合理设计射束安排和先进治疗技术安全实施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To improve local control rate in patients with breast cancer receiving adjuvant radiotherapy after breast conservative surgery, additional boost dose to the tumor bed could be delivered simultaneously via the simultaneous integrated boost (SIB) modulated technique. However, the position of tumor bed kept changing during the treatment course as the treatment position was aligned to bony anatomy. This study aimed to analyze the positional uncertainties between bony anatomy and tumor bed, and a topology-based approach was derived to stratify patients with high variation in tumor bed localization. METHODS: Sixty patients with early-stage breast cancer or ductal carcinoma in situ were enrolled. All received adjuvant whole breast radiotherapy with or without local boost via SIB technique. The delineation of tumor bed was defined by incorporating the anatomy of seroma, adjacent surgical clips, and any architectural distortion on computed tomography simulation. A total of 1740 on-board images were retrospectively analyzed. Positional uncertainty of tumor bed was assessed by four components: namely systematic error (SE), and random error (RE), through anterior-posterior (AP), cranial-caudal (CC), left-right (LR) directions and couch rotation (CR). Age, tumor location, and body-mass factors including volume of breast, volume of tumor bed, breast thickness, and body mass index (BMI) were analyzed for their predictive role. The appropriate margin to accommodate the positional uncertainty of the boost volume was assessed, and the new plans with this margin for the tumor bed was designed as the high risk planning target volume (PTV-H) were created retrospectively to evaluate the impact on organs at risk. RESULTS: In univariate analysis, a larger breast thickness, larger breast volume, higher BMI, and different tumor locations correlated with a greater positional uncertainty of tumor bed. However, BMI was the only factor associated with displacements of surgical clips in the multivariate analysis and patients with higher BMI were stratified as high variation group. When image guidance was aligned to bony structures, the SE and RE of clip displacement were consistently larger in the high variation group. The corresponding PTV-H margins for the high- and low-variation groups were 7, 10, 10 mm and 4, 9, 6 mm in AP, CC, LR directions, respectively. The heart dose between the two plans was not significantly different, whereas the dosimetric parameters for the ipsilateral lung were generally higher in the new plans. CONCLUSIONS: In patients with breast cancer receiving adjuvant radiotherapy, a higher BMI is associated with a greater positional uncertainty of the boost tumor volume. More generous margin should be considered and it can be safely applied through proper design of beam arrangement with advanced treatment techniques.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Lee PY, Lin CY, Chen SW, et al. A topology-based method to mitigate the dosimetric uncertainty caused by the positional variation of the boost volume in breast conservative radiotherapy. Radiat Oncol. 2017. PMID: 28320428. doi:10.1186/s13014-017-0801-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。